PCSK9 Inhibitors: Are We on the Verge of a Breakthrough?

Yang, E

PCSK9 Inhibitors: Are We on the Verge of a Breakthrough? [electronic resource] - Clinical pharmacology and therapeutics Dec 2015 - 590-601 p. digital

Publication Type: Journal Article; Review

1532-6535

10.1002/cpt.263 doi


Animals
Antibodies, Monoclonal--adverse effects
Anticholesteremic Agents--adverse effects
Biomarkers--blood
Cardiovascular Diseases--etiology
Cholesterol, LDL--blood
Diffusion of Innovation
Drug Discovery--trends
Humans
Hypercholesterolemia--blood
Molecular Targeted Therapy--trends
Proprotein Convertase 9
Proprotein Convertases--antagonists & inhibitors
Risk Factors
Serine Endopeptidases--genetics
Serine Proteinase Inhibitors--adverse effects